Nektar Therapeutics Reports First Quarter 2023 Financial Results

/PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the first quarter ended March 31, 2023. Cash and investments in...

Related Keywords

San Francisco ,California ,United States ,Alabama ,Eli Lilly ,Howardw Robin ,David Rosen ,Vivian Wu ,Exchange Commission On ,Nektar Therapeutics ,Recent Business ,Discuss First Quarter ,Home Page ,Nektar Earnings Call ,Annual Report ,Exchange Commission ,